Company Profile
Amphastar Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- AMPH
- Exchange:
- NASDAQ
- Sector:
- Pharmaceuticals
- Location:
- United States
Stock performance
19.81 USD (-2.12%)
Close
Last updated: August 6, 2026
814M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, AMPH closed down 2.12% at $19.81. No new same-company headline was identified in the current news window.
Company overview
Business overview
Amphastar Pharmaceuticals is a specialty pharmaceutical company with injectable, inhalation, and other complex generic products.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Amphastar sits in specialty pharma and generics.
Business Model Characteristics
The company relies on product launches, manufacturing execution, and a mix of injectable and respiratory products.
Position Within the Biotechnology Landscape
Amphastar is a specialty-manufacturing story whose movement depends on product mix and execution rather than biotech catalysts.
Future catalysts
Amphastar's catalysts are Primatene Mist, injectable product execution, and the broader specialty-generic mix. The company tends to improve when manufacturing and product mix stay disciplined.
Recent news
- 01
Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference
Source: Amphastar Pharmaceuticals, Inc.
- 02
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Source: Amphastar Pharmaceuticals, Inc.
- 03
Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary
Source: Amphastar Pharmaceuticals, Inc.
- 04
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021
Source: Amphastar Pharmaceuticals, Inc.
- 05
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection
Source: Amphastar Pharmaceuticals, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Amphastar Pharmaceuticals, Inc. (AMPH)?
Amphastar Pharmaceuticals, Inc. (AMPH) most recently closed at 19.81 USD, a -2.12% move versus the previous session.
What is the market cap of Amphastar Pharmaceuticals, Inc. (AMPH)?
Amphastar Pharmaceuticals, Inc. currently has a market capitalization of 814M USD on BioPharmSignal.
What does Amphastar Pharmaceuticals, Inc. do?
Amphastar Pharmaceuticals is a specialty pharmaceutical company with injectable, inhalation, and other complex generic products.
On which exchange is AMPH stock listed?
Amphastar Pharmaceuticals, Inc. (AMPH) is associated with NASDAQ, United States, Pharmaceuticals.
What is Amphastar?
Amphastar's catalysts are Primatene Mist, injectable product execution, and the broader specialty-generic mix.
Which conditions is Amphastar Pharmaceuticals, Inc. targeting with Amphastar?
Amphastar's catalysts are Primatene Mist, injectable product execution, and the broader specialty-generic mix.
How does Amphastar Pharmaceuticals, Inc. describe recent progress with Amphastar?
Amphastar's catalysts are Primatene Mist, injectable product execution, and the broader specialty-generic mix.
What is Pharmaceuticals?
Amphastar Pharmaceuticals is a specialty pharmaceutical company with injectable, inhalation, and other complex generic products.